{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-24-000082","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.172669+00:00","generated_at":"2026-05-31T06:33:57.199410+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Edwards completes $4.2B sale of Critical Care to BD, adds $1.5B buyback","bullets":["Closed all-cash sale of Critical Care to BD (NYSE: BDX) for $4.2B.","Board authorized additional $1.5B share repurchase; entered $500M accelerated repurchase.","Total $1B repurchased to date including prior $500M 10b5-1 and open-market buys.","Net proceeds to fund strategic initiatives, prior acquisitions, and share repurchases.","Company to discuss strategy and outlook at Wells Fargo Healthcare Conference on Sept 5."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-24-000082","json":"https://secwatch.observer/filing/0001099800-24-000082.json","markdown":"https://secwatch.observer/filing/0001099800-24-000082.md","text":"https://secwatch.observer/filing/0001099800-24-000082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000082/0001099800-24-000082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980024000082/ew-20240903.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:33:57.199410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}